Literature DB >> 28920468

Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations.

Peter A Kavsak1,2, Chantele Roy3, Paul Malinowski3, Ching-Tong Mark2, Terry Scott2, Lorna Clark2, Shana Lamers3, Craig Ainsworth4.   

Abstract

Background Analytical comparisons between different high-sensitivity cardiac troponin (hs-cTn) assays are important for reassurance of results performed with different methodologies and to identify potential interferences or confounders to result interpretation. Our objective in the present study was to compare Beckman Coulter's latest hs-cTnI assay to Abbott's hs-cTnI assay and to assess agreement between results. Methods Two hundred ethylenediaminetetraacetic acid plasma samples that had clinically reported hs-cTnI results from the Abbott ARCHITECTi2000 that spanned the analytical range were stored (median = 4 h), re-centrifuged and retested for hs-cTnI on the Abbott ARCHITECTi1000 and Beckman Coulter Access2 analysers. Passing-Bablok regression and fold-differences were evaluated, with differences approximately three-fold between results further subjected to Roche hs-cTnT testing and polyethylene glycol precipitation. Results The Beckman and Abbott hs-cTnI concentrations were correlated ( r = 0.95) with Beckman yielding proportionally lower concentrations (slope = 0.78; 95%CI: 0.74-0.85). There were 12 samples that yielded Abbott hs-TnI concentrations ≥3-fold higher than the Beckman hs-cTnI concentrations; of which nine samples from seven different patients had sufficient quantity for additional testing. All seven patients had macrocomplexes as determined with polyethylene glycol precipitation that affected the Abbott hs-cTnI assay. One patient with Abbott hs-cTnI results >1300 ng/L had polyethylene glycol, heterophile antibodies and creatine kinase-MB testing performed which confirmed that a macrocomplex most likely affected the Abbott and Roche (hs-cTnT = 65 ng/L) assays but not the Beckman (hs-cTnI = 12 ng/L) assay. Conclusion The hs-cTnI concentrations obtained from ethylenediaminetetraacetic acid plasma between the Beckman and Abbott assays are highly correlated, with large differences in concentrations (≥3-fold) between Abbott and Beckman assays possible due to macrocomplexes.

Entities:  

Keywords:  High-sensitivity cardiac troponin; analytical variation; macrocomplexes; myocardial injury

Mesh:

Substances:

Year:  2017        PMID: 28920468     DOI: 10.1177/0004563217734883

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1. 

Authors:  Marianne Laguë; Pierre Yves Turgeon; Sébastien Thériault; Christian Steinberg
Journal:  CMAJ       Date:  2022-06-06       Impact factor: 16.859

2.  Description of interference in the measurement of troponin T by a high-sensitivity method.

Authors:  Miguel Aliste-Fernández; Gemma Sole-Enrech; Ruth Cano-Corres; Silvia Teodoro-Marin; Eugenio Berlanga-Escalera
Journal:  Biochem Med (Zagreb)       Date:  2019-06-15       Impact factor: 2.313

3.  A false-positive troponin assay leading to the misdiagnosis of myopericarditis.

Authors:  Marianne Laguë; Pierre Yves Turgeon; Sébastien Thériault; Christian Steinberg
Journal:  CMAJ       Date:  2022-03-28       Impact factor: 8.262

4.  Disagreement between Cardiac Troponin Tests Yielding a Higher Incidence of Myocardial Injury in the Emergency Setting.

Authors:  Peter A Kavsak; Shawn E Mondoux; Janet Martin; Mark K Hewitt; Lorna Clark; Nadia Caruso; Ching-Tong Mark; V Tony Chetty; Craig Ainsworth; Andrew Worster
Journal:  J Cardiovasc Dev Dis       Date:  2021-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.